Progressive stages of "transdifferentiation" from epidermal to mesenchymal phenotype induced by MyoD1 transfection, 5-aza-2'-deoxycytidine treatment, and selection for reduced cell attachment in the human keratinocyte line HaCaT.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 2289354)

Published in J Cell Biol on March 01, 1992

Authors

P Boukamp1, J Chen, F Gonzales, P A Jones, N E Fusenig

Author Affiliations

1: Division of Carcinogenesis and Differentiation In vitro, German Cancer Research Center, Heidelberg.

Articles cited by this

Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36

RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry (1977) 38.82

Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell (1987) 22.17

The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell (1982) 19.91

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol (1988) 16.82

Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell (1989) 8.42

Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A (1989) 7.19

MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell (1989) 6.94

A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J (1989) 6.37

Plasticity of the differentiated state. Science (1985) 6.19

Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell (1980) 5.83

Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J Cell Biol (1982) 5.52

MyoD family: a paradigm for development? Genes Dev (1990) 5.32

Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev (1989) 4.50

Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science (1991) 4.45

Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell (1979) 4.38

Positive autoregulation of the myogenic determination gene MyoD1. Cell (1989) 4.28

A reproducible microanalytical method for the detection of specific RNA sequences by dot-blot hybridization. Anal Biochem (1984) 3.47

Herculin, a fourth member of the MyoD family of myogenic regulatory genes. Proc Natl Acad Sci U S A (1990) 3.30

Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO J (1990) 3.16

Effect of cell history on response to helix-loop-helix family of myogenic regulators. Nature (1990) 2.21

MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc Natl Acad Sci U S A (1990) 2.21

Human cell hybrids: analysis of transformation and tumorigenicity. Science (1982) 2.16

Involucrin synthesis is correlated with cell size in human epidermal cultures. J Cell Biol (1981) 2.14

Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J Biol Chem (1984) 1.96

Assembly of stratum corneum basic protein and keratin filaments in macrofibrils. Nature (1978) 1.96

Selective migration of terminally differentiating cells from the basal layer of cultured human epidermis. J Cell Biol (1984) 1.93

Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab Invest (1983) 1.82

The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am J Clin Pathol (1987) 1.75

Multiple positive and negative 5' regulatory elements control the cell-type-specific expression of the embryonic skeletal myosin heavy-chain gene. Mol Cell Biol (1987) 1.73

Simultaneous expression of two different types of intermediate sized filaments in mouse keratinocytes proliferating in vitro. Differentiation (1979) 1.68

c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res (1990) 1.59

Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res (1987) 1.47

Tonofilament differentiation in human epidermis, isolation and polypeptide chain composition of keratinocyte subpopulations. Exp Cell Res (1983) 1.45

Environmental modulation of the expression of differentiation and malignancy in six human squamous cell carcinoma cell lines. Cancer Res (1985) 1.40

Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am J Pathol (1990) 1.40

Differentiation specific functions in cultured and transplanted mouse keratinocytes: environmental influences on ultrastructure and keratin expression. Differentiation (1984) 1.39

Mouse epidermal cell cultures. II. Isolation, characterization and cultivation of epidermal cells from perinatal mouse skin. Exp Cell Res (1975) 1.39

Formation of cytoskeletal elements during mouse embryogenesis. III. Primary mesenchymal cells and the first appearance of vimentin filaments. Differentiation (1982) 1.34

Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HACAT and in ras-transfected tumorigenic clones. Differentiation (1989) 1.30

Myogenesis and developmental control genes. Curr Opin Cell Biol (1990) 1.29

Activation and repression of myogenesis in somatic cell hybrids: evidence for trans-negative regulation of MyoD in primary fibroblasts. Cell (1990) 1.28

Changes in the pattern of cytokeratin polypeptides in epidermis and hair follicles during skin development in human fetuses. Differentiation (1982) 1.25

Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium. J Pathol (1989) 1.17

Environmental induction of differentiation-specific keratins in malignant mouse keratinocyte lines. Eur J Cell Biol (1986) 1.14

Studies on the synthesis and degradation of a high molecular weight, histidine-rich phosphoprotein from mammalian epidermis. Biochim Biophys Acta (1981) 1.07

Smooth muscle cells can express cytokeratins of "simple" epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. Am J Pathol (1988) 1.04

Transient coexpression of desmin and cytokeratins 8 and 18 in developing myocardial cells of some vertebrate species. Differentiation (1988) 1.03

Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells. J Virol (1990) 1.01

Epidermal morphogenesis and keratin expression in c-Ha-ras-transfected tumorigenic clones of the human HaCaT cell line. Cancer Res (1991) 0.97

Mesenchyme-mediated and endogenous regulation of growth and differentiation of human skin keratinocytes derived from different body sites. Differentiation (1990) 0.96

Expression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas. Mol Cell Biol (1989) 0.95

Reorganization of intermediate filament cytoskeleton in induced metanephric mesenchyme cells is independent of tubule morphogenesis. Dev Biol (1985) 0.89

A transformation-associated 130-kD cell surface glycoprotein is growth controlled in normal human cells. J Exp Med (1988) 0.89

Cytokeratins and cytokeratin filaments in subpopulations of cultured human and rodent cells of nonepithelial origin: modes and patterns of formation. Differentiation (1989) 0.88

Expression and modification of keratins during terminal differentiation of mammalian epidermis. Curr Top Dev Biol (1987) 0.86

Organotypic culture of outer root sheath cells from human hair follicles using a new culture device. In Vitro Cell Dev Biol (1987) 0.86

Potentiation of MyoD1 activity by 5-aza-2'-deoxycytidine. Cell Growth Differ (1990) 0.81

Epithelial and mesenchymal cell differentiation in the fetal rat genital ducts: changes in the expression of cytokeratin and vimentin type of intermediate filaments and desmosomal plaque proteins. Dev Biol (1986) 0.78

Expression of epithelial antigens Exo-1 and EPM-1 in human epidermal keratinocyte maturation and benign and malignant neoplasia. Cancer Res (1990) 0.77

Articles by these authors

(truncated to the top 100)

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol (1988) 16.82

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A (1990) 16.34

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89

Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA (1998) 11.90

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell (1995) 11.72

Cellular differentiation, cytidine analogs and DNA methylation. Cell (1980) 10.15

Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10

An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature (1994) 8.60

Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell (1997) 8.28

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A (1997) 7.52

Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem (2001) 7.35

Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature (1995) 7.05

Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity (1995) 6.91

Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science (2001) 6.47

Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell (1979) 6.47

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A (1980) 6.31

Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science (1996) 5.92

Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell (1997) 5.92

The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell (2001) 5.86

Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev (1994) 5.68

Genetic diversity and disease control in rice. Nature (2000) 5.34

An essential role for Rac in Ras transformation. Nature (1995) 5.34

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol (2009) 5.08

5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science (1990) 4.80

Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell (1999) 4.76

The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res (1999) 4.74

Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res (1997) 4.65

Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med (2000) 4.54

Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology (2002) 4.45

Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res (2001) 4.38

Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med (1994) 4.34

Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31

Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature (1999) 4.29

Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res (1995) 4.28

Demethylation-induced developmental pleiotropy in Arabidopsis. Science (1996) 4.25

Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS (2000) 4.24

Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys (1992) 4.12

Fringe is a glycosyltransferase that modifies Notch. Nature (2000) 4.09

Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler (1994) 4.09

A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci U S A (2000) 4.06

Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med (2011) 4.04

Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene (1987) 4.02

Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. Cancer Res (1986) 3.95

Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J Cell Biol (2001) 3.92

Identification of a nuclear receptor that is activated by farnesol metabolites. Cell (1995) 3.92

B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med (2000) 3.89

Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J (2005) 3.84

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83

Genetic analysis of BRCA1 function in a defined tumor cell line. Mol Cell (1999) 3.83

Two regulatory genes of the maize anthocyanin pathway are homologous: isolation of B utilizing R genomic sequences. Plant Cell (1989) 3.83

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell (1999) 3.76

Submucosal endoscopic esophageal myotomy: a novel experimental approach for the treatment of achalasia. Endoscopy (2007) 3.75

Pooled exposure-response analyses and risk assessment for lung cancer in 10 cohorts of silica-exposed workers: an IARC multicentre study. Cancer Causes Control (2001) 3.74

Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell (1995) 3.70

Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene (2009) 3.64

A role for Rho in Ras transformation. Proc Natl Acad Sci U S A (1995) 3.59

TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell (1995) 3.56

Directional guidance of neuronal migration in the olfactory system by the protein Slit. Nature (1999) 3.51

The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ (2009) 3.43

Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (1995) 3.39

Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38

Enhancement of blue-light sensitivity of Arabidopsis seedlings by a blue light receptor cryptochrome 2. Proc Natl Acad Sci U S A (1998) 3.34

A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med (1998) 3.32

5-methylcytosine, gene regulation, and cancer. Adv Cancer Res (1983) 3.27

Pulsed-field fingerprinting of listeriae: identification of genomic divisions for Listeria monocytogenes and their correlation with serovar. Appl Environ Microbiol (1994) 3.24

Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature (1998) 3.23

A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol (2000) 3.23

Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature (2001) 3.09

Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol (2000) 3.08

Oxidative chemistry of peroxynitrite. Methods Enzymol (1994) 3.03

Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia (2003) 3.00

Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res (1994) 2.98

Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation (2000) 2.97

Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry (1999) 2.92

Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase. Proc Natl Acad Sci U S A (1999) 2.83

Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res (1998) 2.83

Predicting survival using simple clinical variables: a case study in traumatic brain injury. J Neurol Neurosurg Psychiatry (1999) 2.83

Huntingtin interacts with a family of WW domain proteins. Hum Mol Genet (1998) 2.81

Altering gene expression with 5-azacytidine. Cell (1985) 2.79

VDJ recombination. Immunol Today (1992) 2.74

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA (1998) 2.70

Bcl-2 family proteins are essential for platelet survival. Cell Death Differ (2007) 2.67

DNA methylation decreases in aging but not in immortal cells. Science (1983) 2.67

Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol (1995) 2.66

Clinical and genetic studies of Birt-Hogg-Dubé syndrome. J Med Genet (2002) 2.65

Prolonged photoresponses in transgenic mouse rods lacking arrestin. Nature (1997) 2.64

The Arabidopsis sex1 mutant is defective in the R1 protein, a general regulator of starch degradation in plants, and not in the chloroplast hexose transporter. Plant Cell (2001) 2.63

Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med (2000) 2.61

Halting angiogenesis suppresses carcinoma cell invasion. Nat Med (1997) 2.61

The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut (1999) 2.60

DNA methylation: past, present and future directions. Carcinogenesis (2000) 2.58

Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev (1996) 2.58

Cytosine methylation does not affect binding of transcription factor Sp1. Proc Natl Acad Sci U S A (1988) 2.56

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med (1998) 2.54

Human CDC6/Cdc18 associates with Orc1 and cyclin-cdk and is selectively eliminated from the nucleus at the onset of S phase. Mol Cell Biol (1998) 2.54

The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol (1998) 2.53

Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol (1998) 2.52

Characterization of a Na+/H+ antiporter gene of Escherichia coli. Proc Natl Acad Sci U S A (1987) 2.51

Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport (2000) 2.49

p16 gene in uncultured tumours. Nature (1994) 2.47